메뉴 건너뛰기




Volumn 211, Issue , 2017, Pages 5-8

Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel

Author keywords

ATM; cancer; CHEK2; next generation sequencing; somatic variants; TP53

Indexed keywords

ADULT; AGED; APC GENE; ARTICLE; ATM GENE; BRCA2 GENE; CDH1 GENE; CHEK2 GENE; GENETIC SCREENING; GENETIC VARIABILITY; GERMLINE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MSH6 GENE; NBN GENE; NEXT GENERATION SEQUENCING; ONCOGENE; PALB2 GENE; PATHOGENICITY; PERIPHERAL LYMPHOCYTE; PMS2 GENE; STK11 GENE; TP53 GENE; TUMOR SUPPRESSOR GENE; BLOOD; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; LYMPHOCYTE; METABOLISM; NEOPLASM; PHYSIOLOGY; PROCEDURES;

EID: 85014515062     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2017.01.002     Document Type: Article
Times cited : (42)

References (15)
  • 1
    • 84930531402 scopus 로고    scopus 로고
    • Gene-panel sequencing and the prediction of breast-cancer risk
    • 1 Easton, D.F., Pharoah, P.D., Antoniou, A.C., et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372 (2015), 2243–2257.
    • (2015) N Engl J Med , vol.372 , pp. 2243-2257
    • Easton, D.F.1    Pharoah, P.D.2    Antoniou, A.C.3
  • 2
    • 73949135028 scopus 로고    scopus 로고
    • Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
    • 2 Malcikova, J., Smardova, J., Rocnova, L., et al. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage. Blood 114 (2009), 5307–5314.
    • (2009) Blood , vol.114 , pp. 5307-5314
    • Malcikova, J.1    Smardova, J.2    Rocnova, L.3
  • 3
    • 84864255882 scopus 로고    scopus 로고
    • The origin and evolution of mutations in acute myeloid leukemia
    • 3 Welch, J.S., Ley, T.J., Link, D.C., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150 (2012), 264–278.
    • (2012) Cell , vol.150 , pp. 264-278
    • Welch, J.S.1    Ley, T.J.2    Link, D.C.3
  • 4
    • 84920024296 scopus 로고    scopus 로고
    • Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
    • 4 Genovese, G., Kahler, A.K., Handsaker, R.E., et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 371 (2014), 2477–2487.
    • (2014) N Engl J Med , vol.371 , pp. 2477-2487
    • Genovese, G.1    Kahler, A.K.2    Handsaker, R.E.3
  • 5
    • 84925518008 scopus 로고    scopus 로고
    • Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
    • 5 Wong, T.N., Ramsingh, G., Young, A.L., et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 518 (2015), 552–555.
    • (2015) Nature , vol.518 , pp. 552-555
    • Wong, T.N.1    Ramsingh, G.2    Young, A.L.3
  • 6
    • 84920053873 scopus 로고    scopus 로고
    • Age-related clonal hematopoiesis associated with adverse outcomes
    • 6 Jaiswal, S., Fontanillas, P., Flannick, J., et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371 (2014), 2488–2498.
    • (2014) N Engl J Med , vol.371 , pp. 2488-2498
    • Jaiswal, S.1    Fontanillas, P.2    Flannick, J.3
  • 7
    • 84930003179 scopus 로고    scopus 로고
    • Age-related mutations associated with clonal hematopoietic expansion and malignancies
    • 7 Xie, M., Lu, C., Wang, J., et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 20 (2014), 1472–1478.
    • (2014) Nat Med , vol.20 , pp. 1472-1478
    • Xie, M.1    Lu, C.2    Wang, J.3
  • 8
    • 84973288294 scopus 로고    scopus 로고
    • Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 2.2016
    • NCCN Clinical Practice Guidelines in Oncology [Internet]. 2016 March 3; Available at
    • 8 Daly, M., Pilarski, R., Axilbund, J.E., et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 2.2016. NCCN Clinical Practice Guidelines in Oncology [Internet]. 2016 March 3; Available at http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf, 2016.
    • (2016)
    • Daly, M.1    Pilarski, R.2    Axilbund, J.E.3
  • 9
    • 84926610163 scopus 로고    scopus 로고
    • Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk
    • 9 Judkins, T., Leclair, B., Bowles, K., et al. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk. BMC Cancer, 15, 2015, 215.
    • (2015) BMC Cancer , vol.15 , pp. 215
    • Judkins, T.1    Leclair, B.2    Bowles, K.3
  • 10
    • 84940449545 scopus 로고    scopus 로고
    • Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer
    • 10 Kapoor, N.S., Curcio, L.D., Blakemore, C.A., et al. Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Oncol 22 (2015), 3282–3288.
    • (2015) Ann Surg Oncol , vol.22 , pp. 3282-3288
    • Kapoor, N.S.1    Curcio, L.D.2    Blakemore, C.A.3
  • 11
    • 84945468475 scopus 로고    scopus 로고
    • Patients tested at a laboratory for hereditary cancer syndromes show an overlap for multiple syndromes in their personal and familial cancer histories
    • 11 Saam, J., Arnell, C., Theisen, A., et al. Patients tested at a laboratory for hereditary cancer syndromes show an overlap for multiple syndromes in their personal and familial cancer histories. Oncology 89 (2015), 288–293.
    • (2015) Oncology , vol.89 , pp. 288-293
    • Saam, J.1    Arnell, C.2    Theisen, A.3
  • 12
    • 84918798338 scopus 로고    scopus 로고
    • Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel
    • 12 Tung, N., Battelli, C., Allen, B., et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121 (2015), 25–33.
    • (2015) Cancer , vol.121 , pp. 25-33
    • Tung, N.1    Battelli, C.2    Allen, B.3
  • 13
    • 84965051096 scopus 로고    scopus 로고
    • Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer
    • 13 Tung, N., Lin, N.U., Kidd, J., et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34 (2016), 1460–1468.
    • (2016) J Clin Oncol , vol.34 , pp. 1460-1468
    • Tung, N.1    Lin, N.U.2    Kidd, J.3
  • 14
    • 84939839583 scopus 로고    scopus 로고
    • Identification of a variety of mutations in cancer predisposition genes in patients with suspected lynch syndrome
    • 14 Yurgelun, M.B., Allen, B., Kaldate, R.R., et al. Identification of a variety of mutations in cancer predisposition genes in patients with suspected lynch syndrome. Gastroenterology 149 (2015), 604–613.
    • (2015) Gastroenterology , vol.149 , pp. 604-613
    • Yurgelun, M.B.1    Allen, B.2    Kaldate, R.R.3
  • 15
    • 0036071261 scopus 로고    scopus 로고
    • The diagnostic applications of saliva—a review
    • 15 Kaufman, E., Lamster, I.B., The diagnostic applications of saliva—a review. Crit Rev Oral Biol Med 13 (2002), 197–212.
    • (2002) Crit Rev Oral Biol Med , vol.13 , pp. 197-212
    • Kaufman, E.1    Lamster, I.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.